Correlation Between Cannara Biotech and Amotiv

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Amotiv at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Amotiv into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannara Biotech and Amotiv Limited, you can compare the effects of market volatilities on Cannara Biotech and Amotiv and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Amotiv. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Amotiv.

Diversification Opportunities for Cannara Biotech and Amotiv

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cannara and Amotiv is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Amotiv Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amotiv Limited and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Amotiv. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amotiv Limited has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Amotiv go up and down completely randomly.

Pair Corralation between Cannara Biotech and Amotiv

Assuming the 90 days trading horizon Cannara Biotech is expected to generate 8.12 times more return on investment than Amotiv. However, Cannara Biotech is 8.12 times more volatile than Amotiv Limited. It trades about 0.02 of its potential returns per unit of risk. Amotiv Limited is currently generating about -0.03 per unit of risk. If you would invest  72.00  in Cannara Biotech on September 27, 2024 and sell it today you would lose (2.00) from holding Cannara Biotech or give up 2.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cannara Biotech  vs.  Amotiv Limited

 Performance 
       Timeline  
Cannara Biotech 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.
Amotiv Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amotiv Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Cannara Biotech and Amotiv Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannara Biotech and Amotiv

The main advantage of trading using opposite Cannara Biotech and Amotiv positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Amotiv can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amotiv will offset losses from the drop in Amotiv's long position.
The idea behind Cannara Biotech and Amotiv Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
CEOs Directory
Screen CEOs from public companies around the world